21/12/2022
: DEA said it found more than 60% of the 72,000 controlled substance prescriptions Truepill filled between September 2020 and September 2022 were for stimulants, including generic forms of Adderall.
An investigation by the Drug Enforcement Administration led to allegations that the company filled prescriptions when prescribers did not possess proper state licensing while others exceeded the 90-day supply limits.